Elm Street Ventures — Full Portfolio

Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.

BiotechDigital HealthHealthtechNew Haven, US

PFPaul Fonteyne(Co-Founder)inSSStephen Strittmatter(Scientific Founder)inSBStephen Bloch(CEO & Co-Founder)inTimothy Siegert(COO, Co-Founder)inTim Siegert, PhD(COO & Co-Founder)JGJennifer Gabler(Executive Officer)in

Co-investorsSPSpring Mountain CapitalCOConnecticut InnovationsWHWHIN

AbbraTech develops a platform technology for the discovery, engineering, and validation of antibodies, targeting disease-relevant proteins that are difficult to address with conventional approaches.

BiotechDeep TechBranford, US

MWMichael Weiner(Founder)in

Co-investorsCOConnecticut Innovations

Ancera develops a software platform for food production that combines analytics, diagnostics, and automation to monitor, predict, and prevent risks such as pathogens and disease.

AgTechAI & Machine LearningFoodTechSaaSBranford, US

AGArjun Ganesan(CEO)inHKHur Koser(Executive Officer, Director)in

BoardUgo DeBlasi(Director)McLeod Christopher(Director)Thomas Livingston(Director)

Co-investorsIAIAG Capital PartnersLALaunchCapitalCOConnecticut Innovations

AtlasXomics develops spatial epigenomics tools, spanning chip fabrication, hardware, and bioinformatics, for researchers studying areas such as cancer and systems biology.

BiotechDeep TechHealthtechNew Haven, US

Gregory Ho(Director)Richard Andersson(Director)

BoardKWKenneth Wang(Investor and entrepreneur (board member))

Co-investorsCOConnecticut Innovations

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.

BiotechDeep TechHardwareMedical DevicesAtlanta, US

AZAlla Zamarayeva(CEO & Co-founder)inTodd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)TSTodd Sulchek(CSO & Co-founder)inAAAlex Alexeev(Co-founder)in

Co-investorsDYDynamk CapitalCOCota CapitalCRCreative Destruction Lab (CDL)EMEmbark VenturesGRGreatPoint VenturesM M Ventures+1 more

San Francisco, US

Eli Luberoff(Executive Officer, Director, Promoter)inVan Dyke Billings, III(Executive Officer)

Co-investorsGVGV (Google Ventures)KAKapor Capital

Device42 provides IT asset management and operations software that gives organizations visibility and control over their data center and cloud infrastructure.

Cloud ComputingData & InfrastructureEnterprise SoftwareIoTSaaSTrumbull, US

Rajneesh Jalan(Executive Officer, Director)RJRaj Jalan(Founder & CEO)in

BoardSteven P. Shwartz(Executive Officer, Director)John Kole(Director)Chris Penner(Director)

Co-investorsALAlpine MeridianCOConnecticut Innovations

Enrich HK supports migrant domestic workers in Hong Kong through financial education, wellness programs, and community initiatives.

FintechHR TechImpact & Social GoodWellness & FitnessHong Kong, HK

SGSuzanne Gendron(Executive Director)inTynna Mendoza(Interim Executive Director)in

Co-investorsAVAVPN

Enrich Biosystems develops TROVO, a fluidics-free benchtop instrument that compartmentalizes standard culture plates into thousands of hydrogel microwells for high-throughput functional screening, imaging, and live recovery of cells.

BiotechHardwareHealthtechBranford, US

Qi Zhao(Executive Officer, Director)Dong Wang(Executive Officer, Director)Cynthia Green(Director)

BoardDaniel Wagner(Director)Christopher McLeod(Director)Jay Teich(Director)

Co-investorsCOConnecticut Innovations

EvolveImmune develops immunotherapy treatments for cancer patients.

BiotechHealthtechMedical DevicesBranford, US

Stephen Bloch(Co-founder and Chief Executive Officer)inDonmienne Leung(Manager)Ian Taylor(Manager)Jay Fine(President, Research and Development)

BoardDYDerek Yoon(Manager)inJasmina Marjanovic(Manager)in

Co-investorsSOSolasta VenturesPFPfizer VenturesPFPfizer Venture InvestmentsTATakeda Ventures

BiotechMedical DevicesNew Haven, US

Scott Phillips(Executive Officer)in

BoardTSTim Shannon(Manager)inLRLiam Ratcliffe(Manager)in

Co-investorsACAccess BiotechnologyCACanaan PartnersCOConnecticut InnovationsFRFrazier Life SciencesRARA CapitalTATaiho Ventures, LLC+1 more

Osmol Therapeutics is a preclinical-stage biotech developing OSM-0205, an intravenous drug intended to prevent chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI) in cancer patients receiving taxane-based therapy.

BiotechHealthtechNew Haven, US

Brian Dixon(Executive Officer, Director)BLBob Linke(President & CEO)inRon Weitzman(Chief Medical Officer)

BoardBarbara Ehrlich(Chief Scientific Advisor)

P2 Science develops green chemistry platform technologies (including its PIOz ozonolysis and PICE polymerization processes) that convert renewable, plant-based oils into functional intermediates, specialty ingredients, and polymers.

BiotechCircular EconomyCleantechNew MaterialsWoodbridge, US

PAPaul Anastas(Co-founder)Patrick Foley(Co-founder & President)inNeil A. Burns(Executive Officer, Director)OEOihana Elizalde(Chief Executive Officer)inBCBrian Chan(Chief Financial Officer)inKevin Gallagher(Director)

Co-investorsXEXeraya CapitalCICircular Innovation FundCOConnecticut InnovationsEMEmerald Technology Ventures AgHGHG VenturesSASafer Made+2 more

Samara Aerospace designs and builds high-performance satellite platforms featuring the Hummingbird satellite bus, which combines pointing stability, agility, and power generation in a compact form for commercial, civil, and national security missions.

Deep TechHardwareSpace TechSuperior, US

PHPatrick Haddox(Co-founder)inVedant(Founder)in

Co-investorsBABalerion Space VenturesGAGaingelsGEGeneral CatalystILIllinois VenturesMAMana VenturesTATamiami Angel+5 more

Saphlux develops monolithic full-color micro-LED display technology and quantum dot COB display panels for AR smart glasses, sports intelligence glasses, and large-format business and home theater screens.

Deep TechHardwareSemiconductorsBranford, US

CCChen Chen(CEO)

BoardHan Jung(Director)

Co-investorsNXNXT Ventures

SeeClickFix 311 CRM by CivicPlus is a 311 platform that lets residents report local issues, request repairs, and send feedback or questions to their local government.

GovTechSaaSNew Haven, US

Charles Kampmann Lasater(Executive Officer, Director)BBBen Berkowitz(Executive Officer, Director)MLMiles Lasater(Director)in

BoardMark Jacobsen(Director)

Co-investorsCOConnecticut InnovationsLALaunchCapitalPUPurpose Built Ventures